logo
Will check if existing building can be used for penguin park: Zoo official

Will check if existing building can be used for penguin park: Zoo official

Time of India2 days ago
Mysuru: The proposed penguin park, which was suggested after shelving a 15-year-old aquarium project at Mysuru zoo, is likely to be another tourist attraction in the city.
After the efforts of the zoo authorities were unsuccessful in securing funds for the aquarium project and convincing the tourism department to take the project forward, it was decided to abandon it.
Tired of too many ads? go ad free now
Now, there is a fresh proposal to establish a penguin park on the lines of Mumbai and Ahmedabad under the PPP model. And, this project requires approximately Rs 70 crore.
Mysuru zoo executive director KN Rangaswamy said that the penguin park project is still in the preliminary stage. The proposal will be submitted after a feasibility study, he stated. The structural stability of the existing defunct building constructed for the aquarium project, where the Penguin Park is planned, will also be studied, he explained.
Dead-end project
However, tourism stakeholders see it as another possible dead-end project, suggesting that the govt provide facilities for tourists instead of making fresh proposals. Many projects have reached a dead end without serving the purpose, and the latest was the aquarium project. The building was constructed after spending crores of rupees, and now the govt is trying to use the defunct building, which requires huge amount of funds.
Stakeholders claimed netas lack vision for tourism development in Mysuru, which receives over 4 million visitors annually.
SKAL International, Mysuru chapter, president CA Jayakumar said a well-defined vision, coupled with measurable goals, ensures projects stay on track. The govt should focus on delivering value, he added.
Meanwhile, KV Rajendra, director of Karnataka Tourism, said the Eco Experience Zone (EEZ) project aims to provide tourists with a better Mysuru experience. Under the Eco Experience Zone initiative, all three popular tourist spots–Mysuru Zoo, Karanji Lake, and Regional Museum of Natural History—situated adjacent to each other, will offer visitors single-entry access for a full day of nature-based activities.
The tender process will be floated soon, he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tata Consumer Products Ltd down for fifth straight session
Tata Consumer Products Ltd down for fifth straight session

Business Standard

time36 minutes ago

  • Business Standard

Tata Consumer Products Ltd down for fifth straight session

Tata Consumer Products Ltd is quoting at Rs 1073.7, down 0.29% on the day as on 13:19 IST on the NSE. The stock tumbled 5.38% in last one year as compared to a 1.83% rally in NIFTY and a 6.71% fall in the Nifty FMCG index. Tata Consumer Products Ltd is down for a fifth straight session today. The stock is quoting at Rs 1073.7, down 0.29% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.45% on the day, quoting at 25036.9. The Sensex is at 82130.42, down 0.45%.Tata Consumer Products Ltd has lost around 0.9% in last one Nifty FMCG index of which Tata Consumer Products Ltd is a constituent, has increased around 2.12% in last one month and is currently quoting at 55910.25, up 0.23% on the day. The volume in the stock stood at 4.88 lakh shares today, compared to the daily average of 11.12 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 1076.6, down 0.41% on the day. Tata Consumer Products Ltd tumbled 5.38% in last one year as compared to a 1.83% rally in NIFTY and a 6.71% fall in the Nifty FMCG index. The PE of the stock is 89.07 based on TTM earnings ending March 25.

Mankind Pharma Ltd spurts 2.92%, gains for five straight sessions
Mankind Pharma Ltd spurts 2.92%, gains for five straight sessions

Business Standard

time36 minutes ago

  • Business Standard

Mankind Pharma Ltd spurts 2.92%, gains for five straight sessions

Mankind Pharma Ltd is quoting at Rs 2653.7, up 2.92% on the day as on 12:44 IST on the NSE. The stock is up 23.51% in last one year as compared to a 1.91% gain in NIFTY and a 7.81% gain in the Nifty Pharma. Mankind Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2653.7, up 2.92% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.37% on the day, quoting at 25055.85. The Sensex is at 82161.62, down 0.41%. Mankind Pharma Ltd has added around 11.97% in last one month. Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has added around 1.97% in last one month and is currently quoting at 22225.9, up 1.11% on the day. The volume in the stock stood at 10.75 lakh shares today, compared to the daily average of 7.73 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 2660.3, up 3.07% on the day. Mankind Pharma Ltd is up 23.51% in last one year as compared to a 1.91% gain in NIFTY and a 7.81% gain in the Nifty Pharma index. The PE of the stock is 56.47 based on TTM earnings ending March 25.

Glenmark Pharmaceuticals Ltd up for third consecutive session
Glenmark Pharmaceuticals Ltd up for third consecutive session

Business Standard

time36 minutes ago

  • Business Standard

Glenmark Pharmaceuticals Ltd up for third consecutive session

Glenmark Pharmaceuticals Ltd is quoting at Rs 2214.7, up 1.54% on the day as on 12:49 IST on the NSE. The stock is up 57.28% in last one year as compared to a 1.88% jump in NIFTY and a 7.85% jump in the Nifty Pharma index. Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting at Rs 2214.7, up 1.54% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.4% on the day, quoting at 25050.1. The Sensex is at 82139.43, down 0.44%. Glenmark Pharmaceuticals Ltd has gained around 31.56% in last one month. Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has gained around 2% in last one month and is currently quoting at 22225.9, up 1.15% on the day. The volume in the stock stood at 27.13 lakh shares today, compared to the daily average of 18.89 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 2223, up 1.92% on the day. Glenmark Pharmaceuticals Ltd is up 57.28% in last one year as compared to a 1.88% jump in NIFTY and a 7.85% jump in the Nifty Pharma index. The PE of the stock is 35.29 based on TTM earnings ending March 25.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store